COMPARISON BETWEEN DIFFERENT DOSES OF A LOCAL ANESTHETIC AGENT IN CONTROLLING ETOMIDATE INDUCED MUSCLE DISORDER
Phase 3
- Conditions
- Health Condition 1: - Health Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2019/02/017653
- Lead Sponsor
- INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES PATNA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.PATIENT OF ASA PHYSICAL STATUS 1 AND 2
2.PATIENTS BETWEEN 20 TO 60 YEARS OF AGE OF EITHER SEX.
3.PATIENTS WILLING TO PARTICIPATE.
4.PATIENTS SCHEDULED TO UNDERGO ELECTIVE SURGERIES UNDER PLANNED GENERAL ANAESTHESIA
Exclusion Criteria
1.PATIENTS REFUSAL TO PARTICIPATE.
2.PATIENTS WITH KNOWN SENSITIVITY TO LIGNOCAINE AND ETOMIDATE.
3.ANTICIPATED DIFFICULT AIRWAY.
4.PREGNANT OR LACTATING FEMALES.
5.IMPAIRED RENAL AND HEPATIC DYSFUNCTION.
6.KNOWN ADRENAL DYSFUNCTION.
7.PSYCHOLOGICAL OR NEUROLOGICAL ABNORMALITIES.
8.CARDIAC CONDUCTION ABNORMALITIES.
9.PATIENTS ON ANTIARRHYTHMIC MEDICATIONS.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method INCIDENCE OF MYOCLONUSTimepoint: 1 MINUTE, 2 MINUTES
- Secondary Outcome Measures
Name Time Method SEVERITY OF MYOCLONUS AND ANY OTHER ADVERSE EFFECTSTimepoint: 1 MINUTE, 2 MINUTES